Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.

Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, McLeod D, Klein EA, Jones JS, Wang S, McAskill T, Mehrotra J, Raghavan B, Partin AW.

BJU Int. 2012 Jul;110(1):56-62. doi: 10.1111/j.1464-410X.2011.10718.x. Epub 2011 Nov 11.

2.

Development of a multiplexed urine assay for prostate cancer diagnosis.

Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B, Robin H, Pelzer A, Schäfer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A.

Clin Chem. 2008 May;54(5):874-82. doi: 10.1373/clinchem.2007.094912. Epub 2008 Mar 13.

3.

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.

Mehrotra J, Varde S, Wang H, Chiu H, Vargo J, Gray K, Nagle RB, Neri JR, Mazumder A.

Prostate. 2008 Feb 1;68(2):152-60.

PMID:
18058812
4.

Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer.

Lo PK, Mehrotra J, D'Costa A, Fackler MJ, Garrett-Mayer E, Argani P, Sukumar S.

Cancer Biol Ther. 2006 Mar;5(3):281-6. Epub 2006 Mar 6.

PMID:
16410723
5.

Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer.

Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, Argani P, Sukumar S.

Cancer Res. 2004 Jul 1;64(13):4442-52.

6.

Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung.

Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukumar S.

Clin Cancer Res. 2004 May 1;10(9):3104-9.

7.

Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.

Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S.

Clin Cancer Res. 2004 Mar 15;10(6):2052-7.

8.

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P.

Int J Cancer. 2003 Dec 20;107(6):970-5.

9.

Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH.

Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, Ko C, Carpenter L, Mehrotra J, Manabe YC, Fleischmann RD, Bishai WR.

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8330-5.

10.

Regulation of virulence genes in Mycobacterium tuberculosis.

Mehrotra J, Bishai WR.

Int J Med Microbiol. 2001 May;291(2):171-82. Review.

PMID:
11437339
11.
12.

Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, selectively augments human T cell response to mycobacterial protein antigens.

Sinha S, Mehrotra J, Bala L, Jaiswal AK, Dhawan BN.

Immunopharmacol Immunotoxicol. 1998 Nov;20(4):579-88.

PMID:
9805236
14.

A major T-cell-inducing cytosolic 23 kDa protein antigen of the vaccine candidate Mycobacterium habana is superoxide dismutase.

Bisht D, Mehrotra J, Dhindsa MS, Singh NB, Sinha S.

Microbiology. 1996 Jun;142 ( Pt 6):1375-83.

PMID:
8704977
16.

Biochemical and developmental effects in rats following in utero exposure to acrylonitrile: a preliminary report.

Mehrotra J, Khanna VK, Husain R, Seth PK.

Ind Health. 1988;26(4):251-5. No abstract available.

Supplemental Content

Loading ...
Support Center